2021–2022 state of our JCMR
Journal of Cardiovascular Magnetic Resonance volume 24, Article number: 75 (2022)
In 2021, there were 136 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR), including 122 original research papers, six reviews, four technical notes, one Society for Cardiovascular Magnetic Resonance (SCMR) guideline, one SCMR position paper, one study protocol, and one obituary (Nathaniel Reichek). The volume was up 53% from 2020 (n = 89) with a corresponding 21% decrease in manuscript submissions from 435 to 345. This led to an increase in the acceptance rate from 24 to 32%. The quality of the submissions continues to be high. The 2021 JCMR Impact Factor (which is released in June 2022) markedly increased from 5.41 to 6.90 placing us in the top quartile of Society and cardiac imaging journals. Our 5 year impact factor similarly increased from 6.52 to 7.25. Fifteen years ago, the JCMR was at the forefront of medical and medical society journal migration to the Open-Access format. The Open-Access system has dramatically increased the availability and JCMR citation. Full-text article requests in 2021 approached 1.5 M!. As I have mentioned, it takes a village to run a journal. JCMR is very fortunate to have a group of very dedicated Associate Editors, Guest Editors, Journal Club Editors, and Reviewers. I thank each of them for their efforts to ensure that the review process occurs in a timely and responsible manner. These efforts have allowed the JCMR to continue as the premier journal of our field. My role, and the entire editorial process would not be possible without the ongoing high dedication and efforts of our managing editor, Jennifer Rodriguez. Her premier organizational skills have allowed for streamlining of the review process and marked improvement in our time-to-decision (see later). As I conclude my 6th and final year as your editor-in-chief, I thank you for entrusting me with the JCMR editorship and appreciate the time I have had at the helm. I am very confident that our Journal will reach new heights under the stewardship of Dr. Tim Leiner, currently at the Mayo Clinic with a seamless transition occurring as I write this in late November. I hope that you will continue to send your very best, high quality CMR manuscripts to JCMR, and that our readers will continue to look to JCMR for the very best/state-of-the-art CMR publications.
The JCMR is the official publication of the Society for Cardiovascular Magnetic Resonance (SCMR). In 2021, the JCMR published 136 articles published in the Journal of Cardiovascular Magnetic Resonance (JCMR), including 122 original research papers, six reviews, four technical notes, one Society for Cardiovascular Magnetic Resonance (SCMR) guideline, one SCMR position paper, one study protocol, and one obituary (Nathaniel Reichek). The 2021 publication volume was up 53% from 2020 (n = 89) with a corresponding 21% decrease in manuscript submissions from 435 to 345. This led to an increase in the acceptance rate from 24 to 32% (the slight mathematical difference in acceptance/submissions is related to submission year and publication year). As might be expected, COVID-19 publications [1,2,3,4,5,6,7,8] and COVID-19 vaccination publications (8) were plentiful, with 8 published in 2021.
In July 2018, the article processing charge (APC) structure changed with SCMR members who are the submitting author paying an APC of only $500, presenting an 82% discount to the full $2680 APC. Reduced APC fees are also available to those from BMC membership institutions, submitting authors from lower income countries, and for those who request a waiver due to financial hardship. APCs are waived for invited reviews and for Society publications.
As for 2020, in 2021, the United States (26%) and China (24%) were the source of 50% of all JCMR publications followed by the United Kingdom (10% and Germany (8%). The top three countries for publications were the United States (31%), United Kingdom (14%) and Germany (10%) (Fig. 1).
Though only one of many journal metrics and not a consideration in our review process, the Impact Factor calculated by Clarivate Analytics is nonetheless a well-recognized metric with which many readers are familiar and is a metric often considered by both authors and readers for submitting and reading manuscripts. I am pleased to report that the 2021 JCMR Impact Factor (which was released in June 2022 and is based on manuscripts published in 2019 (n = 430) and 2020 (n = 633) that were cited in 2021) increased from 5.41 to 6.90!. This impact factor means that the JCMR papers published in 2019 and 2020 were cited on average 6.90 times in 2021. This puts JCMR well positioned in the top quartile (34/142–previously 37/142) of journals in the broad categories of “Cardiac and Cardiovascular Systems” and the top quintile (21/133–previously 20/133) of “Radiology, Nuclear Medicine and Medical Imaging.” Our 2021 5 year impact factor similarly increased from 6.52 to 7.25. The 2022 JCMR impact factor will be released in June 2023.
Perhaps more important than the Impact Factor is the frequency that JCMR articles are accessed. Our open-access format allows for much greater visibility for our authors with the 2021 JCMR annual digital downloads now approaching 1,500,000!!—a threshold not achievable with a subscription/print publication of a relatively small Society journal. Open-access has “leveled the playing field” so that an electronic search allows JCMR manuscripts to rise to awareness and to then be downloaded without cost. This is a great benefit to our readers, to the greater scientific community, and to our authors. Data analytics provided by our publisher, BMC, indicate that the vast majority (72%) of on line manuscript searches are identified from a Google, 9% directly from the JCMR web site, 4% from Pubmed. The largest number of searches are from Europe (38%) followed by the United States (28%).
JCMR editor-in-chief leadership
Dr. Gerald Pohost (Fig. 2) from the University of Alabama at Birmingham and University of Southern California, Los Angeles, CA, USA was the JCMR inaugural editor-in-chief (1999). During his tenure, the JCMR was published in print format by Marcel Dekker, Inc (Fig. 2). In 2007, he was succeeded by Professor Dudley Pennell (Fig. 2) of the Royal Brompton Hospital, London, England. Since December 2016, the JCMR editorial office has been located at the Beth Israel Deaconess Medical Center, Boston, MA, USA under my leadership. My 6 year term will end at the end on December 31, 2022. We are well underway for an organized transition to the 4th JCMR Editor-in-Chief, Dr. Tim Leiner, currently at the Mayo Clinic, Rochester, Minnesota, USA. Throughout this transition, you can continue to contact the JCMR editor-in-chief by using the same email: email@example.com.
2021 JCMR editorial and management team
The JCMR Associate Editors (Table 1) reflect the international and diverse spectrum of the CMR and SCMR field. Dr. Long Ngo (USA) continues to serve as our statistical editor. Drs. Juan Lopez-Mattei (USA) and Purvi Parwani (USA) are busy every week disseminating JCMR news as our Social Media/Twitter editors. Tim has elected to keep most of the current team in place and will be adding several Associate Editors. Stay tuned!
Jennifer Rodriguez (firstname.lastname@example.org) has been our managing editor since January 2021 (Fig. 3). Jennifer has made tremendous progress in keeping me and the entire manuscript review process organized and on schedule. As a result, we have seen a marked decrease in our time to first decision time from a mean of 60 days in 2019 and 2020 to ≤ 40 days since she took the managing editor position in January 2021. I hope our authors have felt this tangible difference. We are fortunate that Jennifer has agreed to continue in her JCMR managing editorial role with Dr. Leiner.
2021 JCMR Journal Club—now with CME!
A highlight of 2021 was the second season of our JCMR Journal. These monthly one-hour webinars are held on the 2nd Wednesday of the month at 11am ET. A link for the monthly registration is on the JCMR (https://jcmr-online.biomedcentral.com/) and SCMR (www.scmr.org) websites. For three years, these monthly JCMR Journal Clubs have been moderated by one of our three Journal Club Editors, Drs. Scott Flamm (clinical), Raymond Kwong (clinical) and Matthias Stuber (non-clinical) (Fig. 4). On a rotating basis, each editor choses a manuscript that was recently published in JCMR. After a brief Journal Club Editor introduction of the topic, the presenting author has a 25–30 min presentation followed by a spirited 30 min discussion. We continue to offer continuing medical education (CME) for reading the manuscript and for July–December 2022 started providing CME for Journal Club attendance. CME for our JCMR Journal Club is another free benefit for SMCR members. Please join your colleagues every month for an informative presentation and discussion. Don’t worry if you missed one. Recordings of the monthly webinars and a CME journal link are provided on the JCMR web site. Check them out! While you can receive CME for reading the manuscript at any time, you can only receive CME for journal club attendance when participating in the live event.
Like other JCMR activities, the JCMR Journal Club is a village effort. In addition to our 3 talented Journal Club editors, I very much appreciate the strong administrative assistance of Sarah Mania (Fig. 4) for the past 18 months. Sarah was responsible for coordinating registration, the speaker presentations, CME, Zoom operations and recording, and subsequent posting of the monthly JCMR Journal Club recording on the SCMR website. The 2021 JCMR Journal Club selections were on a wide variety of topics (Table 2).
Manuscript review process, omissions, and suggestions
I reviewed the manuscript submission process in my report earlier this year  and will not repeat that outline.
All manuscripts are submitted and processed through the http://www.jcmr-online.org website. I encourage all authors to closely follow the guidelines so as not to delay the review process. By far, the most error that leads to review delay continues to be the omission of the names and contact information for at least two suggested reviewers in their submission documents. I ask authors to use JCMR preferred abbreviations (Table 3; https://jcmr-online.biomedcentral.com/submission-guidelines/preparing-your-manuscript/abbreviations) and to use the terms “CMR” and “cardiovascular magnetic resonance” rather than “cardiac magnetic resonance” or “cardiac MRI.” While the abbreviation issue does not delay the review, it adds additional burden to the prepublication editing process.
I encourage authors to carefully consider the number of significant digits and reported p values in their manuscripts. For example, when reporting native T1 and standard deviation, would report to the nearest ms and not to the X.X ms or X.XX ms. While technically accurate, reporting T1 to this level of accuracy has no clinical relevance. Similarly, when reporting p values for the sample sizes of most JCMR publications, a value of < 0.001 is a reasonable limit.
All work submitted to the JCMR must be original and cannot be under consideration by another journal until a decision is made by the JCMR. Though a rare occurrence, we have encountered instances where authors had multiple simultaneous submissions. When we become aware of this, the manuscript is immediately withdrawn from further consideration and the authors are put on administrative warning.
Reviewer recognition—gold star reviewers
Reviewers are a key component to the success of the JCMR. In 2019, we introduced the annual JCMR Gold Star Reviewer recognition program for all those who had (1) reviewed at least 3 manuscripts (2) provided an on-time review and (3) provided a high quality review. For 2021, we also recognized the first JCMR Triple Gold Star Reviewer recognition for those who had received a gold start for 3 consecutive years. The 100 JCMR Gold Star reviewers and inaugural 31 JCMR Triple Gold Star reviewers are listed in Table 4. Please join the ranks of JCMR reviewers and strive to be a Gold Star reviewer! As an added incentive, reviewers have the option to receive continuing medical education (CME) credit for providing a review.
Conflict-of-interest, reviews, SCMR guideline/position manuscripts and SCMR committee papers
Conflict-of-interest manuscripts, those for which a member of the associate editorial board is either an author, acknowledged in the manuscript or closely associated with an author, are independently handled by a Guest Editor (Table 5) chosen by me. Neither I nor any of the associate editorial board are involved with reviewer selection or with manuscript decision. Our managing editorial office assists the Guest Editor with the administrative software/Editorial Manager. If a conflict-of-interest manuscript is accepted, the Guest Editor is recognized in the JCMR publication with the text “Dr. XX served as a JCMR Guest Editor for this manuscript.”
The JCMR does not accept unsolicited reviews. Authors are encouraged to contact the editor-in-chief (email@example.com) before submitting any reviews. In general, we expect reviews to be authored by individuals considered experts in the field and receive considerable attention/downloads. All solicited reviews follow the usual peer-review process. Several reviews were published in 2021, including reviews on 4D flow in tetralogy of Fallot , dark blood CMR techniques , and COVID .
The JCMR is the official publication of the SCMR. As such, SCMR Guidelines and Position papers endorsed by the Full (or Executive) SCMR Board(s) do not undergo peer review. I review these manuscripts for consistency with JCMR style and abbreviations. They are then published in an expeditious manner. Society position papers included documents on Level II/independent practitioner training guidelines , writing standards for guidelines  and SCMR position paper on the role of CMR in women .
SCMR case of the week series
While the JCMR does not accept case reports, for many years, the SCMR web site has an active “Case of the Week” (https://scmr.org/page/caseoftheweekLDGPG) series, currently coordinated by Dr. Sylvia Chen. For the second time, in 2021, we published the prior year’s annual case series as a single manuscript . This unified publication is planned as an annual occurrence in JCMR to allow for these illustrative cases to be more widely available to search engines.
Continuing medical education (CME) JCMR journal club
For over 4 years we have been offering on-line CME credit for the benefit of our clinician readers and is a free benefit for SCMR members -allowing them to more easily fulfill the CME criteria for maintenance of their Level II or III certification . This program has been a great success and was greatly expanded with 14 manuscripts in 2021. (Table 6). Please see http://scmr.peachnewmedia.com/store/provider/custompage.php?pageid=20 for the complete listing.
I am very much a social media novice, but the JCMR continues to be very active on Twitter with the handle “JournalofCMR.” Tweets go out with the publication of each manuscript publication and announcing each Journal Club. This activity is coordinated by our two Social Media editors, Drs. Juan Lopez-Mattei and Purvi Parwani.
Gerald M. Pohost and Dudley Pennell awards
In recognition of the efforts of our inaugural editor-in-chief, Dr. Gerald M. Pohost, (Fig. 3) for the past 15 years, the JCMR has awarded the Pohost Prize to that manuscript deemed by the associate editors and editorial board to be the best/most important manuscript published in the prior year. The associate editors and I select the Pohost finalists (Table 7) and the entire editorial board votes on the top prize. At the virtual 2021 SCMR Scientific Sessions annual meeting, the 15th Gerald M. Pohost Prize was awarded to Dr. Theo Pezel and co-workers for their manuscript “Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing.” . The Pohost Runner-up Prize was awarded to Dr. Angelica Romero Daza and colleagues for their publication, “Mitral valve prolapse multifunctional features by cardiovascular magnetic resonance: more than just a valvular disease” .
At that virtual meeting, we also presented the 4th Dudley Pennell Award in recognition of the foresight of JCMR’s 2nd Editor-in-Chief, Professor Dudley J. Pennell (Fig. 3) to transition the JCMR to the open-access platform (a decision (spearheaded by then SCMR Publications Committee chairman, Dr. Matthias Friedrich). Their decision markedly improved JCMR’s visibility and impact factor. The Pennell award is for that original manuscript that has most contributed to the Journal’s impact factor for the calendar year 3 years prior to the award. The 3rd Dudley J. Pennell Prize was awarded to Dr. Wenjia Bai et al. for their publication, “Automated cardiovascular magnetic resonance image analysis with fully convolutional networks”  with the runner-up Pennell Award was given to Dr. José Fernando Rodríguez -Palomares and colleagues for publication, “Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilation in bicuspid aortic valve disease” .
Stay tuned for the 15th Pohost and 4th Pennell Awards that will presented at the 23nd Scientific Sessions of the Society this February in Ft Lauderdale, Florida, USA!
Tribute to Nathaniel Reichek
Last year the SCMR and the greater CMR community lost one of our founding fathers. Dr. Nathaniel Reichek. Nat was a friend and a true giant in our field. He was literally “in the room” when the SCMR was founded, served as our 3rd president, was a 2017 recipient of the SCMR Gold Medal, and was a tireless advocate for the United States CMR Advocacy Committee. Last year, the SCMR named the Education and Research Fund in his honor. For my tenure as editor-in-chief, Nat was often my “go to” person for conflict-of-interest manuscripts or sounding board. His command of CMR was almost unparalleled, and he readily gave his time to help the Journal and all who inquired of his opinion. While we didn’t agree on every issue, Nat was a gentleman of high integrity and I miss him at multiple levels. We published our first “In Memoriam” in his honor . May his memory be a blessing.
For the past 15 years, the JCMR has been published by BMC, part of Springer Nature and a pioneer of open access publishing. Our current five-year contract with BMC ends at the end of 2022 and the SCMR has embarked on a search for a publisher (may remain with BMC but yet to be determined). Our new editor-in-chief, Tim Leiner is the chair of the committee and an RFP was recently distributed. A decision is expected by mid 2023. Regardless, the Journal of Cardiovascular Magnetic Resonance, JCMR moniker, and Journal contents are owned by the Society. The transition to a new publisher (if this occurs) at the end of 2023 will be seamless to you, our readership.
As in last year’s review, I chose to create a Wordcloud (https://www.wordclouds.com) of the 2020 and 2021 JCMR titles (Fig. 5). As in 2020, the most common JCMR manuscript title words were magnetic, cardiovascular, resonance with 2021 followed by imaging, heart, ventricular and myocardial.
I hope you have found my closing annual “State of our JCMR” informative. I remain the captain until December 31, 2022, but as members of the SCMR, it is really your Journal for which I thank you for allowing me to provide stewardship. I close by again thanking the entire JCMR “village” for contributing to our success. Remember to also join us for our monthly JCMR Journal Club on the second Wednesday of the month at 11am ET!
Wishing you a happy, healthy, and safe 2023. We take great pride in the health care advances enabled by the ongoing advances in CMR. Remember to also take a deep breath every day to enjoy the moment.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or analyzed.
Article processing charge
Continuing medical education
Journal of Cardiovascular Magnetic Resonance
Society for Cardiovascular Magnetic Resonance
Gorecka M, McCann GP, Berry C, Ferreira VM, Moon JC, Miller CA, Chiribiri A, Prasad S, Dweck MR, Bucciarelli-Ducci C, Dawson D, Fontana M, Macfarlane PW, McConnachie A, Neubauer S, Greenwood JP, COVID-HEART investigators. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study. J Cardiovasc Magn Reson. 2021;23(1):77.
Kim JY, Han K, Suh YJ. Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2021;23(1):100.
Webster G, Patel AB, Carr MR, Rigsby CK, Rychlik K, Rowley AH, Robinson JD. Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study. J Cardiovasc Magn Reson. 2021;23(1):86.
Aeschlimann FA, Misra N, Hussein T, Panaioli E, Soslow JH, Crum K, Steele JM, Huber S, Marcora S, Brambilla P, Jain S, Navallas M, Giuli V, Rücker B, Angst F, Patel MD, Azarine A, Caro-Domínguez P, Cavaliere A, Di Salvo G, Ferroni F, Agnoletti G, Bonnemains L, Martins D, Boddaert N, Wong J, Pushparajah K, Raimondi F. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson. 2021;23(1):140.
Galea N, Marchitelli L, Pambianchi G, Catapano F, Cundari G, Birtolo LI, Maestrini V, Mancone M, Fedele F, Catalano C, Francone M. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study. J Cardiovasc Magn Reson. 2021;23(1):68.
Wang H, Li R, Zhou Z, Jiang H, Yan Z, Tao X, Li H, Xu L. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021;23(1):14.
Clark DE, Dendy JM, Li DL, Crum K, Dixon D, George-Durrett K, Parikh AP, Wassenaar JW, Hughes SG, Soslow JH. Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case-control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC). J Cardiovasc Magn Reson. 2021;23(1):106.
Patel YR, Louis DW, Atalay M, Agarwal S, Shah NR. Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. J Cardiovasc Magn Reson. 2021;23(1):101.
Manning WJ. 2021—state of our JCMR. J Cardiovasc Magn Reson. 2022;24(1):14.
Elsayed A, Gilbert K, Scadeng M, Cowan BR, Pushparajah K, Young AA. Four-dimensional flow cardiovascular magnetic resonance in tetralogy of Fallot: a systematic review. J Cardiovasc Magn Reson. 2021;23(1):59.
Holtackers RJ, Van De Heyning CM, Chiribiri A, Wildberger JE, Botnar RM, Kooi ME. Dark-blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of subendocardial scar: a review of current techniques. J Cardiovasc Magn Reson. 2021;23(1):96.
Patel AR, Kelle S, Fontana M, Jacob R, Stojanovska J, Collins J, Patel HN, Francone M, Han Y, Bandettini WP, Bucciarelli-Ducci C, Raman S, Weissman G. SCMR level II/independent practitioner training guidelines for cardiovascular magnetic resonance: integration of a virtual training environment. J Cardiovasc Magn Reson. 2021;23(1):139.
Uretsky S, Aggarwal N, van Heeswijk RB, Rajpal S, Rowin E, Taylor MD, Verjans JW, Wokhlu A, Markl M, Raman SV, Shah DJ. Standards for writing Society for Cardiovascular Magnetic Resonance (SCMR) endorsed guidelines, expert consensus, and recommendations: a report of the publications committee. J Cardiovasc Magn Reson. 2021;23(1):129.
Ordovas KG, Baldassarre LA, Bucciarelli-Ducci C, Carr J, Fernandes JL, Ferreira VM, Frank L, Mavrogeni S, Ntusi N, Ostenfeld E, Parwani P, Pepe A, Raman SV, Sakuma H, Schulz-Menger J, Sierra-Galan LM, Valente AM, Srichai MB. Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR). J Cardiovasc Magn Reson. 2021;23(1):52.
Johnson JN, Mandell JG, Christopher A, Olivieri LJ, Loke YH, Campbell MJ, Darty S, Kim HW, Clark DE, Frischhertz BP, Fish FA, Bailey AL, Mikolaj MB, Hughes SG, Oneugbu A, Chung J, Burdowski J, Marfatia R, Bi X, Craft J, Umairi RA, Kindi FA, Williams JL, Campbell MJ, Kharabish A, Gutierrez M, Arzanauskaite M, Ntouskou M, Ashwath ML, Robinson T, Chiang JB, Lee JCY, Lee MSH, Chen SSM. Society for cardiovascular magnetic resonance 2020 case of the week series. J Cardiovasc Magn Reson. 2021;23(1):108.
Kim RJ, Simonetti OP, Westwood M, et al. Guidelines for training in cardiovascular magnetic resonance (CMR). J Cardiovasc Magn Reson. 2018;20(1):57.
Pezel T, Unterseeh T, Garot P, Hovasse T, Kinnel M, Champagne S, Toupin S, Sanguineti F, Garot J. Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing. J Cardiovasc Magn Reson. 2021;23(1):89.
Romero Daza A, Chokshi A, Pardo P, Maneiro N, Guijarro Contreras A, Larrañaga-Moreira JM, Ibañez B, Fuster V, Fernández Friera L, Solís J, Sanz J. Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease. J Cardiovasc Magn Reson. 2021;23(1):107.
Bai W, Sinclair M, Tarroni G, et al. Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J Cardiovasc Magn Reson. 2018;20(1):65.
Rodríguez-Palomares JF, Dux-Santoy L, Guala A, et al. Aortic flow patterns and wall shear stress maps by 4D-flow cardiovascular magnetic resonance in the assessment of aortic dilatation in bicuspid aortic valve disease. J Cardiovasc Magn Reson. 2018;20(1):28.
Kramer CM, Ferrari V. In Memoriam, Nathaniel M. Reichek, MD, 1941–2021. J Cardiovasc Magn Reson. 2021;23(1):111.
Podlesnikar T, Pizarro G, Fernández-Jiménez R, et al. Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy). J Cardiovasc Magn Reson. 2020;22(1):44.
Pennig L, Lennartz S, Wagner A, et al. Clinical application of free-breathing 3D whole heart late gadolinium enhancement cardiovascular magnetic resonance with high isotropic spatial resolution using Compressed SENSE. J Cardiovasc Magn Reson. 2020;22(1):89.
Raphael CE, Mitchell F, Kanaganayagam GS, et al. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation. J Cardiovasc Magn Reson. 2021;23(1):26.
Pezel T, Unterseeh T, Kinnel M, et al. Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease. J Cardiovasc Magn Reson. 2021;23(1):43.
Le TT, Ang BWY, Bryant JA, Chin CY, Yeo KK, Wong PEH, Ho KW, Tan JWC, Lee PT, Chin CWL, Cook SA. Multiparametric exercise stress cardiovascular magnetic resonance in the diagnosis of coronary artery disease: the EMPIRE trial. J Cardiovasc Magn Reson. 2021;23(1):17.
Zhang Y, Mui D, Chirinos JA, Zamani P, Ferrari VA, Chen Y, Han Y. Comparing cardiovascular magnetic resonance strain software packages by their abilities to discriminate outcomes in patients with heart failure with preserved ejection fraction. J Cardiovasc Magn Reson. 2021;23(1):55.
Meloni A, Martini N, Positano V, De Luca A, Pistoia L, Sbragi S, Spasiano A, Casini T, Bitti PP, Allò M, Sanna PMG, De Caterina R, Sinagra G, Pepe A. Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications. J Cardiovasc Magn Reson. 2021;23(1):70.
Giusca S, Steen H, Montenbruck M, Patel AR, Pieske B, Erley J, Kelle S, Korosoglou G. Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021;23(1):92.
Nelsson A, Kanski M, Engblom H, et al. Pulmonary blood volume measured by cardiovascular magnetic resonance: influence of pulmonary transit time methods and left atrial volume. J Cardiovasc Magn Reson. 2021;23(1):123.
Edelman RR, Leloudas N, Pang J, Koktzoglou I. Dark blood cardiovascular magnetic resonance of the heart, great vessels, and lungs using electrocardiographic-gated three-dimensional unbalanced steady-state free precession. J Cardiovasc Magn Reson. 2021;23(1):127.
Kato S, Fukui K, Kodama S, Azuma M, Nakayama N, Iwasawa T, Kimura K, Tamura K, Utsunomiya D. Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction. J Cardiovasc Magn Reson. 2021;23(1):112.
Pezel T, Unterseeh T, Garot P, et al. Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing. J Cardiovasc Magn Reson. 2021;23(1):89.
van Cauteren YJM, Smulders MW, Theunissen RALJ, Gerretsen SC, Adriaans BP, Bijvoet GP, Mingels AMA, van Kuijk SMJ, Schalla S, Crijns HJGM, Kim RJ, Wildberger JE, Heijman J, Bekkers SCAM. Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. J Cardiovasc Magn Reson. 2021;23(1):40.
Marlevi D, Sotelo JA, Grogan-Kaylor R, Ahmed Y, Uribe S, Patel HJ, Edelman ER, Nordsletten DA, Burris NS. False lumen pressure estimation in type B aortic dissection using 4D flow cardiovascular magnetic resonance: comparisons with aortic growth. J Cardiovasc Magn Reson. 2021;23(1):51.
Hajhosseiny R, Rashid I, Bustin A, Munoz C, Cruz G, Nazir MS, Grigoryan K, Ismail TF, Preston R, Neji R, Kunze K, Razavi R, Chiribiri A, Masci PG, Rajani R, Prieto C, Botnar RM. Clinical comparison of sub-mm high-resolution non-contrast coronary CMR angiography against coronary CT angiography in patients with low-intermediate risk of coronary artery disease: a single center trial. J Cardiovasc Magn Reson. 2021;23(1):57.
Nakamura S, Ishida M, Nakata K, Ichikawa Y, Takase S, Takafuji M, Ito H, Nakamori S, Kurita T, Dohi K, Sakuma H. Long-term prognostic value of whole-heart coronary magnetic resonance angiography. J Cardiovasc Magn Reson. 2021;23(1):56.
Gupta AN, Avery R, Soulat G, Allen BD, Collins JD, Choudhury L, Bonow RO, Carr J, Markl M, Elbaz MSM. Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR. J Cardiovasc Magn Reson. 2021;23(1):138.
Hopman LHGA, Mulder MJ, van der Laan AM, Demirkiran A, Bhagirath P, van Rossum AC, Allaart CP, Götte MJW. Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive left atrial fibrosis. J Cardiovasc Magn Reson. 2021;23(1):131.
Jordan AN, Fulford J, Gooding K, Anning C, Wilkes L, Ball C, Pamphilon N, Mawson D, Clark CE, Shore AC, Sharp ASP, Bellenger NG. Morphological and functional cardiac consequences of rapid hypertension treatment: a cohort study. J Cardiovasc Magn Reson. 2021;23(1):122.
Kato S, Fukui K, Kodama S, Azuma M, Nakayama N, Iwasawa T, Kimura K, Tamura K, Utsunomiya D. Prognostic value of resting coronary sinus flow determined by phase-contrast cine cardiovascular magnetic resonance in patients with known or suspected coronary artery disease. J Cardiovasc Magn Reson. 2021;23(1):97.
Rankin AJ, Mangion K, Lees JS, Rutherford E, Gillis KA, Edy E, Dymock L, Treibel TA, Radjenovic A, Patel RK, Berry C, Roditi G, Mark PB. Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal. J Cardiovasc Magn Reson. 2021;23(1):125.
Edy E, Rankin AJ, Lees JS, Barrientos PH, Woodward R, Stoumpos S, Koktzoglou I, Edelman RR, Radjenovic A, Mark PB, Roditi GH. Cardiovascular magnetic resonance for the detection of descending thoracic aorta calcification in patients with end-stage renal disease. J Cardiovasc Magn Reson. 2021;23(1):85.
Li S, He J, Xu J, Zhuang B, Wu B, Wei B, Huang J, Yin G, Chen X, Zhu Z, Wang H, Zhao S, Lu M. Patients who do not fulfill criteria for hypertrophic cardiomyopathy but have unexplained giant T-wave inversion: a cardiovascular magnetic resonance mid-term follow-up study. J Cardiovasc Magn Reson. 2021;23(1):67.
Loke YH, Capuano F, Cleveland V, Mandell JG, Balaras E, Olivieri LJ. Moving beyond size: vorticity and energy loss are correlated with right ventricular dysfunction and exercise intolerance in repaired Tetralogy of Fallot. J Cardiovasc Magn Reson. 2021;23(1):98.
Seraphim A, Knott KD, Beirne AM, Augusto JB, Menacho K, Artico J, Joy G, Hughes R, Bhuva AN, Torii R, Xue H, Treibel TA, Davies R, Moon JC, Jones DA, Kellman P, Manisty C. Use of quantitative cardiovascular magnetic resonance myocardial perfusion mapping for characterization of ischemia in patients with left internal mammary coronary artery bypass grafts. J Cardiovasc Magn Reson. 2021;23(1):82.
Thompson EW, Kamesh Iyer S, Solomon MP, Li Z, Zhang Q, Piechnik S, Werys K, Swago S, Moon BF, Rodgers ZB, Hall A, Kumar R, Reza N, Kim J, Jamil A, Desjardins B, Litt H, Owens A, Witschey WRT, Han Y. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2021;23(1):120.
Zghaib T, Te Riele ASJM, James CA, Rastegar N, Murray B, Tichnell C, Halushka MK, Bluemke DA, Tandri H, Calkins H, Kamel IR, Zimmerman SL. Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/cardiomyopathy: prevalence, patterns, and association with arrhythmias. J Cardiovasc Magn Reson. 2021;23(1):58.
WJM receives an annual stipend from BMC for his role as JCMR editor-in-chief.
Ethics approval and consent to participate
Consent for publication
The author declares that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Manning, W.J. 2021–2022 state of our JCMR. J Cardiovasc Magn Reson 24, 75 (2022). https://doi.org/10.1186/s12968-022-00909-6